Lanadelumab

ATC B06AC05 · 9 markets · 24 records

Lanadelumab 9 markets · 24 records Forms

AU 5 records · 4 strengths

300 mg/2 mLinjectionTAKHZYRO also in GB·SG
300 mginjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe+1TAKHZYRO lanadelumab 300mg/2mL solution for injection vial also in ES unknown
150 mginjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe also in ES unknown

Records without a stated strength · 1 Takhzyro PFS

GB 4 records · 2 strengths

300 mg/2 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled pens+2Takhzyro 300mg/2ml solution for injection pre-filled syringes、Takhzyro 300mg/2ml solution for injection vials also in AU·SG
150 mg/1 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled syringes

CA 4 records · 2 strengths

150 mgliquidTAKHZYRO also in US
150 mg/1 mLliquidTAKHZYRO

US 3 records · 3 strengths

150 mgliquidTAKHZYRO also in CA
300 mg/2 mLliquidTAKHZYRO
300 mg/2.25 mLinjectionNo trade name

SG 2 records · 2 strengths

300 mg/2 mLinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML also in AU·GB
150 mg/mLinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML

ES 2 records · 2 strengths

300 mginjectionTAKHZYRO PRECARGADA also in AU
150 mginjectionTAKHZYRO PRECARGADA also in AU

TW 1 records · 1 strengths

Records without a stated strength · 1 Takhzyro solution for injection、得釋腫注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 TAKHZYRO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
300 mg/2 mL injection	not recorded	Takhzyro 300mg/2ml solution for injection pre-filled pens Takhzyro 300mg/2ml solution for injection pre-filled syringes Takhzyro 300mg/2ml solution for injection vials	not recorded	TAKHZYRO	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	not recorded	TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe TAKHZYRO lanadelumab 300mg/2mL solution for injection vial	not recorded	TAKHZYRO PRECARGADA	not recorded	not recorded	not recorded
150 mg liquid	TAKHZYRO	not recorded	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg injection	not recorded	not recorded	not recorded	TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe	not recorded	TAKHZYRO PRECARGADA	not recorded	not recorded	not recorded
300 mg/2 mL liquid	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL liquid	not recorded	not recorded	TAKHZYRO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/2.25 mL injection	No trade name	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL injection	not recorded	Takhzyro 300mg/2ml solution for injection pre-filled syringes	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/mL injection	not recorded	not recorded	not recorded	not recorded	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Takhzyro PFS	not recorded	not recorded	not recorded	TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML	TAKHZYRO
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Takhzyro solution for 得釋腫注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · SG · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.